ATC Abstracts

American Transplant Congress abstracts

2017 American Transplant Congress

April 29-May 3, 2017 in Chicago, IL

View by Title View Sessions
View by Date

Saturday, April 29, 2017

5:30pm-7:30pm
mRNA Biomarkers in Renal Allograft Protocol Biopsies Detected by the Nanostring Platform Predict Tolerance in Non-Human Primates.

M. Matsunami,1 T. Oura,1 I. Rosales,2 R.-N. Smith,2 B. Adam,3 M. Mengel,3 A. Cosimi,1 R. Colvin,2 T. Kawai.1

Poster Session A: Diagnostics/Biomarkers Session I  •  Hall D1
5:30pm-7:30pm
Mycophenolate Dose Reductions Are Not Associated with De Novo Donor-Specific Antibodies.

S. Davis, J. Gralla, P. Klem, A. Wiseman, J. Cooper.

Poster Session A: Antibody Mediated Rejection in Kidney Transplant Recipients I  •  Hall D1
5:30pm-7:30pm
Mycophenolic Acid Needs Ca2+ to Exert Its Anti-inflammatory Action via Shedding of Toll-Like Receptor4 and Tumor Necrosis Factor Receptor 1.

J. Kim,1 W. Yang,1 C. Baek,1 N. Han,2 S.-K. Park.1

Poster Session A: Immunosuppression  •  Hall D1
5:30pm-7:30pm
Naïve and Interferon-gamma Activated Mesenchymal Stem Cells Differentially Affect Immune Responses In Vitro and In Vivo.

R. Patil,1 K. Premanand,1 L. Halliday,1 E. Szilagyi,1 M. Willman,2 J. Yu,1 R. Hickey,1 D. Berman,2 A. Antony,1 F. Pan,1 X. Wang,1 K. McHenry,4 D. Salomon,3 N. Kenyon,2 A. Bartholomew.1

Poster Session A: Cellular & Bone Marrow Transplantation Session I  •  Hall D1
5:30pm-7:30pm
Nafamostat Mesilate Ameliorates Ischemia-Reperfusion Renal Injury via Anti-Apoptotic Mechanism.

D. Choi,1 J. Jeong,2 H. Bae,1 Y. Ham,1 K. Lee,1 K. Na.1

Poster Session A: Ischemic Injury and Organ Preservation Session I  •  Hall D1
5:30pm-7:30pm
Neutering Worsens Liver Ischemia/Reperfusion Injury in Both Male and Female Mice.

D. Murken,1 D. Aufhauser Jr,1 S. Concors,1 Z. Wang,1 G. Ge,1 W. Hancock,2 M. Levine.1

Poster Session A: Ischemic Injury and Organ Preservation Session I  •  Hall D1
5:30pm-7:30pm
Neutropenia in Kidney and Liver Transplant Recipients: Risk Factors and Consequences.

T. Mavrakanas,1 M. Fournier,2 S. Clairou,2 J. Amiel,2 D. Vinh,3 C. Coursol,2 D. Thirion,2 M. Cantarovich.4

Poster Session A: Kidney Complications I  •  Hall D1
5:30pm-7:30pm
New Approach for Targeted Immunotherapy in Vascularized Composite Allotransplantation.

F. Feturi,1 H. Wang,2 Y. Brudno,2 V. Erbas,3 Z. Zhang,3 H. Sahin,3 D. Mooney,2 V. Gorantla,3 R. Venkataramanan.1

Poster Session A: Immunosuppression  •  Hall D1
5:30pm-7:30pm
NKG2C+ NK Cell Adaptive Response and the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients.

D. Redondo,1 M. Crespo,1 J. Yélamos,2 A. Muntasell,2 M. Pérez-Sáez,1 C. Vilchez,3 J. Pascual,1 M. Lóez-Botet.2

Poster Session A: Kidney Complications I  •  Hall D1
5:30pm-7:30pm
Non-Directed Donors (NDD) Less Than 25 Years.

D. Larson, J. Wiseman, A. Roman, D. Berglund, H. Ibrahim, A. Matas.

Poster Session A: Living Donor Kidney Transplant I  •  Hall D1